real-world data

The keynote presenter at HIMSS’ Accelerate Health event shares his game plan for how stakeholders can use big data to improve the quality, safety and effectiveness of drug therapies.

(Photo credit: HIMSSTV)

By  Mallory Hackett 12:35 pm March 19, 2021
As the world begins to see a light at the end of the COVID-19 tunnel, healthcare leaders have begun strategizing on how to take the lessons learned and apply them to a post-pandemic environment. “What we really want to be able to do is leverage many of those learnings that we garnered from this experience and really institutionalize those in the health system as we move forward, and how we...
By  Dave Muoio 01:55 pm November 5, 2020
A recently published review of real-world claims data suggests that opioid use disorder patients prescribed Pear Therapeutics' reSET-O digital therapeutic, alongside pharmacotherapy, had fewer clinical encounters and subsequently decreased medical costs over a six-month period. The study was funded by Pear, coauthored by a Pear employee and published in the journal Expert Review of...
A woman types on her cellphone
By  Laura Lovett 02:17 pm October 28, 2020
It’s no secret that real-world data is becoming a hot topic in the sphere of clinical trials and healthcare. A new study published by JMIR found that patients with multiple sclerosis were able to capture their symptoms via a tracking app called elevateMS. Researchers also found that engagement was highest among those who had a doctor’s referral.  “The elevateMS study app captured the real-world...
By  Dave Muoio 03:09 pm October 12, 2020
As healthcare becomes more digitized and clinical treatments shift away from one-size-fits-all therapies, the industry will need to become more critical about how it's employing and curating health data. For vendors and providers, it's about understanding what tools are at their disposal and how they can be implemented to maintain and improve the standard of care. But for regulators like the FDA...
By  Dave Muoio 11:32 am October 12, 2020
Datavant, a data sharing technology startup for providers and life science companies, last week closed $40 million in Series B funding. Transformation Capital headlined the raise, which saw contributions from new backers Johnson & Johnson Innovation - JJDC and Cigna Ventures in addition to those of prior investors Roivant Sciences and Flex Capital. All told, the new funding brings Datavant's...
By  Laura Lovett 01:36 pm September 2, 2020
PicnicHealth, a startup that helps patients access and share their medical records, raked in $25 million in new Series B funding round led by Felicis Ventures.  This comes roughly two years after the California company raised $10 million in its Series A round.  As part of the new deal Sundeep Peechu, managing director at Felicis Ventures will take a seat on PicnicHealth’s board of directors. ...
By  Dave Muoio 11:35 am August 26, 2020
Real-world evidence (RWE) technology startup Aetion has extended last year's $63 million Series B with a new $19 million raise. The funds come as strategic investments from Johnson & Johnson Innovation, JJDC, EDBI and Greenspring Associates, all three of which are new supporters of the company. WHAT IT DOES Founded in 2013, the company's platform provides insights from RWE to decision-makers...
By  Dave Muoio 03:28 pm December 18, 2019
OM1, a Boston-based artificial intelligence platform for clinical real-world evidence, has raised $50 million in Series C funding. Scale Venture Partners led the round consisting of support from prior backers General Catalyst, Polaris Partners and 7wire Ventures. WHAT THEY DO OM1’s cloud platform employs AI machine learning organize and analyze large datasets for real-world measures of clinical...
By  Dave Muoio 03:00 pm December 5, 2019
The FDA and National Institutes of Health are tapping the clinical community and a newly launched mobile platform in its search for novel infectious disease interventions. Called CURE ID, the online data repository will allow clinicians to report instances in which existing FDA-approved drugs are used to successfully treat infections. In particular, the tool captures clinical outcomes in cases...
By  Dave Muoio 02:10 pm September 11, 2019
Myia Labs has raised $10 million in a Series A funding round led by Mercy Virtual, which pledged $5 million after deploying the startup’s AI and consumer wearable monitoring platform among its patients over the last few years. Other investors in the round include Zetta Venture Partners, BootstrapLabs, Boston Consulting Group and B Capital Group, all of which participated in last year’s $6.75...